Moderna has pulled the filing for FDA approval of its flu/COVID combination vaccine. The biotech plans to resubmit later this year with the phase 3 flu vaccine efficacy data the agency wants to see.

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine ...

"The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19," said Stéphane Bancel, Chief Executive Officer of ...

Moderna has “voluntarily” withdrawn its application to the US Food and Drug Administration (FDA) for approval of its Covid-19 and flu combination vaccine amid a recent tightening of regulatory ...

The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with ...

Moderna is down 33.4% since the beginning of the year, and at $27.99 per share, it is trading 83.2% below its 52-week high of $166.61 from May 2024. Investors who bought $1,000 worth of Moderna ...

FDA Approves Moderna's New Lower-Dose COVID-19 Vaccine The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option. The new vaccine ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it. It's not a replacement for the company’s existing shot, but a second option.Video above ...

Cheng Xin / Getty Images Shares of Moderna surged to lead S&P 500 gainers in early afternoon trading Tuesday, hours after the Food and Drug Administration (FDA) issued new guidance for COVID-19 ...

The US Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the ...